GLAXO GROUP LTD. v. Leavitt

ORDER

DAVIS, District Judge.

In this court’s April 6, 2007, Memorandum Opinion Setting Forth Findings of Fact and Conclusions of Law, the court included findings, inter alia, as to the net profit per unit of generic fluticasone marketed by intervenor Roxane Laboratories, Inc., between February 2006 and September 2006. See 481 F.Supp.2d 434 (D.Md.2007). The opinion was filed and posted to the Court’s website on Friday, April 6, 2007. On Monday, April 9, 2007, Roxane filed a motion, which was subsequently amended, seeking to have the court recall its opinion and to substitute a redacted version.…